The cohort study for live-style associated liver disease
Phase 4
- Conditions
- AFLD
- Registration Number
- JPRN-UMIN000020303
- Lead Sponsor
- Department of Endocrinology and Metabolism Kyoto Prefectural University of Medicine
- Brief Summary
Multiple regression analyses demonstrated that change in fat-to-muscle mass ratio was associated with the rate of change in CAP (beta= 0.38, p < 0.001) or rate of change in LSM (beta= 0.21, p = 0.026).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 143
Inclusion Criteria
Not provided
Exclusion Criteria
We excluded the patients without NAFLD, the definition is described below. Exclusion criteria was set as no data of lever stiffness measurement, or no data of bio impedance analysis. After initial registration, the patients, with two or more elastography and bioelectrical impedance body composition evaluations, were extracted.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of the controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) determined by FibroScan (Echosens, Paris, France).
- Secondary Outcome Measures
Name Time Method